Glidum MF 2 500 ER

Glidum-MF 2-500 ER combines Metformin Hydrochloride Prolonged Release (500 mg) and Glimepiride (2 mg) to effectively manage type 2 diabetes mellitus. Metformin works by improving insulin sensitivity and decreasing hepatic glucose production while Glimepiride stimulates insulin secretion from the pancreas. This combination therapy helps maintain optimal blood sugar levels and reduces the risk of diabetes-related complications. The extended-release formulation provides a steady release of medication enhancing patient compliance and overall treatment efficacy.